|
Table 22-4. Whitmore-Jewett staging system for prostate cancer. |
|
A1 |
≤ 3 foci of carcinoma and ≤ 5% of tissue in resection for benign disease has cancer, Gleason sum < 7 |
|
A2 |
> 3 foci of carcinoma and > 5% of tissue in resection for benign disease has cancer, Gleason sum ≥ 7 |
|
B1 |
Palpable nodule ≤ 1.5 cm, confined to prostate |
|
B2 |
Palpable nodule > 1.5 cm, confined to prostate |
|
C1 |
Palpable extracapsular extension |
|
C2 |
Palpable seminal vesicle involvement |
|
D0 |
Clinically localized disease, with negative bone scan but elevated serum acid phosphatase |
|
D1 |
Pelvic lymph node metastases |
|
D2 |
Bone metastases |
|
D3 |
Hormone-refractory prostate cancer |
